Among tested single autoantibody markers, anti-MAGEA4 was found to have good diagnostic potential for detecting early stage CRC (sensitivity=11%; 95% CI, 4−28%) and advanced adenomas (sensitivity=12%; 95% CI, 7−20%) in our analysis. This evidence concerns the gene MAGEA4 and adenoma.